BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,253,494 | +901.9% | 59,711 | +1253.1% | 0.16% | +736.8% |
| Q4 2022 | $224,931 | -5.5% | 4,413 | 0.0% | 0.02% | -20.8% |
| Q3 2022 | $238,000 | -15.9% | 4,413 | 0.0% | 0.02% | -11.1% |
| Q2 2022 | $283,000 | -17.3% | 4,413 | 0.0% | 0.03% | -10.0% |
| Q1 2022 | $342,000 | -17.2% | 4,413 | -8.3% | 0.03% | -11.8% |
| Q4 2021 | $413,000 | +6.7% | 4,813 | 0.0% | 0.03% | 0.0% |
| Q3 2021 | $387,000 | -22.6% | 4,813 | -22.4% | 0.03% | -19.0% |
| Q2 2021 | $500,000 | -12.0% | 6,205 | -7.9% | 0.04% | -16.0% |
| Q1 2021 | $568,000 | +5.2% | 6,735 | 0.0% | 0.05% | 0.0% |
| Q4 2020 | $540,000 | -28.0% | 6,735 | -27.8% | 0.05% | -27.5% |
| Q3 2020 | $750,000 | -8.3% | 9,324 | -1.9% | 0.07% | -12.7% |
| Q2 2020 | $818,000 | +6.1% | 9,502 | 0.0% | 0.08% | -10.2% |
| Q1 2020 | $771,000 | -6.7% | 9,502 | -3.8% | 0.09% | +23.9% |
| Q4 2019 | $826,000 | -4.4% | 9,877 | 0.0% | 0.07% | -10.1% |
| Q3 2019 | $864,000 | +4.2% | 9,877 | -2.5% | 0.08% | +3.9% |
| Q2 2019 | $829,000 | +0.7% | 10,127 | 0.0% | 0.08% | -2.6% |
| Q1 2019 | $823,000 | +68.3% | 10,127 | +36.2% | 0.08% | +23.8% |
| Q4 2018 | $489,000 | -14.7% | 7,433 | 0.0% | 0.06% | -1.6% |
| Q3 2018 | $573,000 | +3.8% | 7,433 | -0.5% | 0.06% | 0.0% |
| Q2 2018 | $552,000 | +10.6% | 7,473 | -2.7% | 0.06% | +6.7% |
| Q1 2018 | $499,000 | +0.6% | 7,677 | 0.0% | 0.06% | +7.1% |
| Q4 2017 | $496,000 | +17.0% | 7,677 | +13.6% | 0.06% | +12.0% |
| Q3 2017 | $424,000 | +0.7% | 6,755 | -2.9% | 0.05% | -3.8% |
| Q2 2017 | $421,000 | +16.6% | 6,955 | 0.0% | 0.05% | +15.6% |
| Q1 2017 | $361,000 | +17.2% | 6,955 | 0.0% | 0.04% | +12.5% |
| Q4 2016 | $308,000 | -6.9% | 6,955 | 0.0% | 0.04% | -11.1% |
| Q3 2016 | $331,000 | +5.1% | 6,955 | 0.0% | 0.04% | +4.7% |
| Q2 2016 | $315,000 | -4.0% | 6,955 | -13.0% | 0.04% | -8.5% |
| Q1 2016 | $328,000 | +3.5% | 7,995 | -3.6% | 0.05% | +2.2% |
| Q4 2015 | $317,000 | +21.9% | 8,297 | +4.7% | 0.05% | +12.2% |
| Q3 2015 | $260,000 | -92.8% | 7,927 | -84.7% | 0.04% | -92.5% |
| Q2 2015 | $3,628,000 | -46.2% | 51,878 | -47.3% | 0.55% | -46.2% |
| Q1 2015 | $6,748,000 | -6.1% | 98,504 | +0.5% | 1.02% | -6.2% |
| Q4 2014 | $7,187,000 | +8.5% | 98,057 | +6.2% | 1.09% | -1.3% |
| Q3 2014 | $6,627,000 | +0.6% | 92,335 | +1.3% | 1.10% | +0.5% |
| Q2 2014 | $6,590,000 | +8.0% | 91,145 | +9.9% | 1.09% | +0.6% |
| Q1 2014 | $6,101,000 | +7.4% | 82,912 | +1.5% | 1.09% | +5.7% |
| Q4 2013 | $5,679,000 | +9.0% | 81,651 | +3.0% | 1.03% | -3.2% |
| Q3 2013 | $5,210,000 | -51.9% | 79,311 | -49.3% | 1.06% | -8.0% |
| Q2 2013 | $10,836,000 | +95.4% | 156,428 | +104.9% | 1.16% | -4.0% |
| Q1 2013 | $5,545,000 | – | 76,336 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |